Of note, EZH2 can act as a co-activator of other transcription factors upon phosphorylation of Serine21 in prostate cancer cells[49] opening up the possibility that EZH2 could act as both a transcriptional repressor and co-activator in epileptogenesis. The gene discussed is EZH2; the disease is prostate carcinoma.